Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3667)
All Articles published online
|
Mar 21, 2012 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nattiv R, Wojcicki JM, Garnett EA, Gupta N, Heyman MB. High-dose infliximab for treatment of pediatric ulcerative colitis: A survey of clinical practice. World J Gastroenterol 2012; 18(11): 1229-1234 [PMID: 22468086 DOI: 10.3748/wjg.v18.i11.1229] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i11/1229.htm |
| Number | Citing Articles |
| 1 |
Shomron Ben-Horin, Yehuda Chowers. Tailoring anti-TNF therapy in IBD: drug levels and disease activity. Nature Reviews Gastroenterology & Hepatology 2014; 11(4): 243 doi: 10.1038/nrgastro.2013.253
|
| 2 |
N. S. Ding, A. Hart, P. De Cruz. Systematic review: predicting and optimising response to anti‐TNF therapy in Crohn's disease – algorithm for practical management. Alimentary Pharmacology & Therapeutics 2016; 43(1): 30 doi: 10.1111/apt.13445
|
| 3 |
Jiri Bronsky, Lissy de Ridder, Frank M. Ruemmele, Anne Griffiths, Stephan Buderus, Ondrej Hradsky, Almuthe Christina Hauer. Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases. Journal of Pediatric Gastroenterology and Nutrition 2019; 68(5): 676 doi: 10.1097/MPG.0000000000002233
|
| 4 |
Steffen Dan‐Nielsen, Vibeke Wewer, Anders Paerregaard, Lars F. Hansen, Rasmus G. Nielsen, Aksel Lange, Christian Jakobsen. Does Infliximab Prevent Colectomy in Acute and Chronic Active Ulcerative Colitis?. Journal of Pediatric Gastroenterology and Nutrition 2014; 58(6): 768 doi: 10.1097/MPG.0000000000000340
|
| 5 |
Ruben J. Colman, Jasbir Dhaliwal, Michael J. Rosen. Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision Medicine. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.634739
|
| 6 |
H.-I. Huppertz, H.W. Lehmann. Evidenz der Therapie chronisch-entzündlicher Erkrankungen in Kindheit und Adoleszenz mit Biologika. Zeitschrift für Rheumatologie 2014; 73(10): 907 doi: 10.1007/s00393-014-1398-8
|
| 7 |
Logan Jerger, Jeffrey S. Hyams. Special considerations for biologic medications in pediatric ulcerative colitis. Expert Opinion on Biological Therapy 2020; 20(4): 429 doi: 10.1080/14712598.2020.1685492
|
| 8 |
Marina Aloi, Federica Nuti, Laura Stronati, Salvatore Cucchiara. Advances in the medical management of paediatric IBD. Nature Reviews Gastroenterology & Hepatology 2014; 11(2): 99 doi: 10.1038/nrgastro.2013.158
|
| 9 |
Konstantinos Papamichael, Ann Gils, Paul Rutgeerts, Barrett G. Levesque, Séverine Vermeire, William J. Sandborn, Niels Vande Casteele. Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD. Inflammatory Bowel Diseases 2015; 21(1): 182 doi: 10.1097/MIB.0000000000000202
|
| 10 |
Bethany R. Sharpless, Fernando del Rosario, Zarela Molle-Rios, Elora Hilmas. Use of Electronic Health Record Tools to Facilitate and Audit Infliximab Prescribing. The Journal of Pediatric Pharmacology and Therapeutics 2018; 23(1): 18 doi: 10.5863/1551-6776-23.1.18
|